Your account is not claimed yet. You can sign up with ORCID to claim your account.

Martin Roatsch

Years Active: 2017-2019
Publications (10 Years): 3

Deutsche Forschungsgemeinschaft

Monash University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Deutsche Forschungsgemeinschaft Jul 1o 2020

Germany

Science Manager - Graduate Schools and Research Careers

Education History

Monash University Feb 22o 2009 - Mar 31o 2009

Australia

BSC

Publications

Piotr H Małecki, Nicole Rüger, Martin Roatsch, Oxana Krylova, Andreas Link, Manfred Jung, Udo Heinemann, Manfred S Weiss
Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases. ChemMedChem 14 (21) (2019)
Martin Roatsch, Inga Hoffmann, Martine I Abboud, Rebecca L Hancock, Hanna Tarhonskaya, Kuo-Feng Hsu, Sarah E Wilkins, Tzu-Lan Yeh, Kerstin Lippl, Kerstin Serrer, Isabelle Moneke, Theresa D Ahrens, Dina Robaa, Sandra Wenzler, Nicolas P F Barthes, Henriette Franz, Wolfgang Sippl, Silke Lassmann, Sven Diederichs, Erik Schleicher, Christopher J Schofield, Akane Kawamura, Roland Schüle, Manfred Jung
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases. ACS chemical biology 14 (8) (2019)
Christian Lis, Stefan Rubner, Martin Roatsch, Angela Berg, Tyler Gilcrest, Darwin Fu, Elizabeth Nguyen, Anne-Marie Schmidt, Harald Krautscheid, Jens Meiler, Thorsten Berg
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells. Scientific reports 7 (1) (2017)

Martin Roatsch.css-eqlu8i{font-size:small;padding-left:4px;}